62 related articles for article (PubMed ID: 3886413)
1. The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk.
Rjasanowski I; Michaelis D; Dietz H; Witt S; Köhler E; Knospe S
Exp Clin Endocrinol; 1985 Feb; 85(1):70-4. PubMed ID: 3886413
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.
Dobersen MJ; Scharff JE; Ginsberg-Fellner F; Notkins AL
N Engl J Med; 1980 Dec; 303(26):1493-8. PubMed ID: 7001237
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
5. Islet cell surface antibodies (ICSA) in subjects with a previous mumps infection--a prospective study over a 4 year period.
Schulz B; Michaelis D; Hildmann W; Witt S; Hehmke B; Rjasanowski I
Exp Clin Endocrinol; 1987 Aug; 90(1):62-70. PubMed ID: 3311781
[TBL] [Abstract][Full Text] [Related]
6. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
7. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
[TBL] [Abstract][Full Text] [Related]
8. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
Negishi K; Kawazu S; Ishii J; Kanazawa Y
J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
[TBL] [Abstract][Full Text] [Related]
9. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
10. Determination of islet cell surface antibodies in first-degree relatives of type 1 diabetic patients using rat insulinoma cells.
Ziegler B; Heinke P; Schlosser M; Rjasanowski I; Michaelis D; Ziegler M
Diabetes Res; 1989 Sep; 12(1):25-9. PubMed ID: 2698302
[TBL] [Abstract][Full Text] [Related]
11. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
Kohnert KD; Hehmke B; Fält K; Ziegler M
Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
Knospe S; Köhler E; Klöting I
Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
[TBL] [Abstract][Full Text] [Related]
13. A population survey of pancreatic islet cell antibodies.
Rodger B; Whittingham S; Martin FI; Hawkins BR; Dawkins RL; Welborn TA
Clin Exp Immunol; 1980 Jan; 39(1):125-9. PubMed ID: 6993063
[TBL] [Abstract][Full Text] [Related]
14. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
Peters WH; Lester FT; Kohnert KD; Hildmann W
Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
[TBL] [Abstract][Full Text] [Related]
15. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
16. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
[TBL] [Abstract][Full Text] [Related]
17. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
18. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
20. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
Köhler E; Knospe S; Besch W; Michaelis D; Rjasanowski I
Exp Clin Endocrinol; 1989; 94(3):357-62. PubMed ID: 2698355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
